Bassel El-Rayes, MD
Emory University Winship Cancer Institute · Emory University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bassel El-Rayes, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:14 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01807156 · Phase II Trial of Tivozanib in Advanced Hepatocellular CancerEmory University · terminated · Hepatocellular Cancer · principal investigator
- Ph1NCT01554969 · Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal CancerEmory University · completed · Rectal Cancer · principal investigator
- Ph1NCT01469572 · Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic MetastasesEmory University · completed · Neuroendocrine Tumors · principal investigator
- Ph1NCT01434459 · Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary OriginEmory University · terminated · Pancreatic Neoplasms, Cholangiocarcinoma · principal investigator
- Ph2NCT01334710 · A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular CancerEmory University · terminated · Liver Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.